New Data Shows 45 Percent Of Patients With Stage 1 Hypertension Reached Normotension With BENICAR(R) And BENICAR HCT(R)
May 15th 2008Drug InformationClinical Trials
Daiichi Sankyo, Inc. announced that data presented at the American Society of Hypertension’s Twenty-Third Annual Scientific Meeting (ASH 2008) in New Orleans demonstrates that a cumulative 45 percent of patients with stage 1 hypertension treated with a regimen of BENICAR(R) (olmesartan medoxomil) and BENICAR HCT(R) (olmesartan medoxomil/hydrochlorothiazide) were able to safely and effectively achieve a normotensive blood pressure,
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
